Table 4. Demographic and clinical characteristics associated with uveitis status in survivors in study of ophthalmic sequelae after Ebola virus disease, Sierra Leone*.
| Characteristics | Total, N = 521 | Uveitis, n = 69 | No uveitis, n = 452 | OR (95% CI) | p value |
|---|---|---|---|---|---|
| Age, mean (SD), n = 496 |
31.1 (16.0) |
29.7 (12.7) |
31.3 (16.5) |
0.97 (0.95–0.99) |
0.048 |
| Sex, N = 510 | 1.78 (1.03–3.05)† | 0.036 | |||
| F | 285 (55.9) | 46 (16.1) | 239 (83.9) | ||
| M |
236 (45.3) |
13 (9.7) |
223 (90.3) |
|
|
| Days in ETU, mean (SD), n = 184 | 26.8 (21.4) | 22.7 (12.3) | 27.4 (22.5) | 0.99 (0.97–1.01) | 0.182 |
| Previous eye exam, n = 513 | 444 (86.5) | 67 (15.1) | 377 (84.9) | 5.95 (1.42–24.88) | 0.006 |
| History of cataract, n = 510 | 42 (8.2) | 16 (38.1) | 26 (61.9) | 4.82 (2.43– 9.56) | <0.001 |
| History of uveitis, n = 510 | 51 (10.0) | 12 (17.4) | 39 (8.8) | 2.17 (1.07–4.39) | 0.030 |
| Vision loss symptoms, n = 510 | 134 (26.3) | 26 (19.4) | 108 (21.2) | 1.86 (1.09–3.18) | 0.026 |
*Values are no. (%) except as indicated. ETU, Ebola treatment unit; OR, odds ratio. †OR is the odds of uveitis for women vs. men.